Product Benefits

• Targeted Anti-Inflammatory Action: Dacivo contains Upadacitinib, a selective Janus Kinase (JAK) inhibitor that precisely targets the enzymes responsible for inflammatory signaling within immune cells. This helps to interrupt the cycle of chronic inflammation.

• Comprehensive Arthritis Control: Indicated for multiple forms of inflammatory arthritis, including moderately to severely active Rheumatoid Arthritis and Psoriatic Arthritis, helping to reduce pain, stiffness, and joint swelling, and slowing structural joint damage.

• Relief for Skin Conditions: Effective in treating moderate to severe Atopic Dermatitis (Eczema) by reducing the chronic inflammation and itching associated with the condition.

• Treatment for Spondyloarthritis: Used for active Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in adults who have not responded well to other therapies.

• Effective for IBD: Indicated for moderate to severe Ulcerative Colitis and Crohn's Disease, helping to achieve and maintain clinical remission.

• Convenient Oral Dosage: Taken as a once-daily tablet, offering an effective and convenient alternative to injectable therapies for chronic inflammatory diseases.

Since Dacivo (Upadacitinib) is a prescription-only medication for serious inflammatory conditions, the information provided is for educational purposes.